Centers for Disease Control and Prevention initiatives to prevent hepatitis C virus infection: a selective update

Bryce D Smith1, Cynthia Jorgensen, Jon E Zibbell

  • 1Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA 30333, USA.

Insights

Hepatitis C virus (HCV) infection poses a significant public health challenge, particularly for the 1945-1965 birth cohort. The Centers for Disease Control and Prevention (CDC) is implementing targeted prevention strategies, including policy, education, and research.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Epidemiology

Background:

  • Hepatitis C virus (HCV) infection presents a complex public health issue with high chronic infection rates and increasing disease burden.
  • A significant majority of chronic HCV infections are found in individuals born between 1945 and 1965.
  • Limited awareness among healthcare professionals, at-risk populations, and the general public complicates prevention efforts.

Purpose of the Study:

  • To outline the Centers for Disease Control and Prevention's (CDC) initiatives to enhance primary and secondary prevention of HCV infection.
  • To address the challenges posed by low testing and treatment rates and rising incidence linked to injection drug use.
  • To highlight specific CDC efforts, including policy development, educational campaigns, and applied research.

Main Methods:

  • Development of specific HCV testing recommendations for the Baby Boomer generation (born 1945-1965).
  • Conducting research and evaluation studies in settings serving individuals who inject drugs.
  • Implementing a national viral hepatitis education campaign targeting diverse audiences.

Main Results:

  • The CDC is actively developing and implementing a multi-faceted approach to combat HCV.
  • Efforts focus on improving knowledge and access to testing and treatment across key demographics.
  • Initiatives aim to reduce HCV incidence and disease progression through enhanced prevention.

Conclusions:

  • Targeted interventions are crucial for controlling the Hepatitis C virus epidemic.
  • The CDC's comprehensive strategy addresses policy, education, and research to improve HCV prevention and outcomes.
  • Raising awareness and improving access to care are key to mitigating the impact of HCV infection.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Standard Precaution01:26

Standard Precaution

Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...